ABSTRACT
The Integrator complex can terminate RNA polymerase II (Pol II) in the promoter-proximal region of genes. Previous work has shed light on how Integrator binds to the paused elongation complex consisting of Pol II, the DRB sensitivity-inducing factor (DSIF) and the negative elongation factor (NELF) and how it cleaves the nascent RNA transcript1, but has not explained how Integrator removes Pol II from the DNA template. Here we present three cryo-electron microscopy structures of the complete Integrator-PP2A complex in different functional states. The structure of the pre-termination complex reveals a previously unresolved, scorpion-tail-shaped INTS10-INTS13-INTS14-INTS15 module that may use its 'sting' to open the DSIF DNA clamp and facilitate termination. The structure of the post-termination complex shows that the previously unresolved subunit INTS3 and associated sensor of single-stranded DNA complex (SOSS) factors prevent Pol II rebinding to Integrator after termination. The structure of the free Integrator-PP2A complex in an inactive closed conformation2 reveals that INTS6 blocks the PP2A phosphatase active site. These results lead to a model for how Integrator terminates Pol II transcription in three steps that involve major rearrangements.
Subject(s)
Cryoelectron Microscopy , Models, Molecular , Protein Phosphatase 2 , RNA Polymerase II , RNA Polymerase II/metabolism , RNA Polymerase II/chemistry , RNA Polymerase II/ultrastructure , Protein Phosphatase 2/metabolism , Protein Phosphatase 2/chemistry , Protein Phosphatase 2/ultrastructure , Transcription Termination, Genetic , Humans , Transcription Factors/metabolism , Transcription Factors/chemistry , Protein Binding , Transcriptional Elongation Factors/metabolism , Transcriptional Elongation Factors/chemistry , Nuclear Proteins/metabolism , Nuclear Proteins/chemistry , Nuclear Proteins/ultrastructure , Protein Subunits/metabolism , Protein Subunits/chemistryABSTRACT
Progression through the cell cycle is controlled by regulated and abrupt changes in phosphorylation1. Mitotic entry is initiated by increased phosphorylation of mitotic proteins, a process driven by kinases2, whereas mitotic exit is achieved by counteracting dephosphorylation, a process driven by phosphatases, especially PP2A:B553. Although the role of kinases in mitotic entry is well established, recent data have shown that mitosis is only successfully initiated when the counterbalancing phosphatases are also inhibited4. Inhibition of PP2A:B55 is achieved by the intrinsically disordered proteins ARPP195,6 and FAM122A7. Despite their critical roles in mitosis, the mechanisms by which they achieve PP2A:B55 inhibition is unknown. Here, we report the single-particle cryo-electron microscopy structures of PP2A:B55 bound to phosphorylated ARPP19 and FAM122A. Consistent with our complementary NMR spectroscopy studies, both intrinsically disordered proteins bind PP2A:B55, but do so in highly distinct manners, leveraging multiple distinct binding sites on B55. Our extensive structural, biophysical and biochemical data explain how substrates and inhibitors are recruited to PP2A:B55 and provide a molecular roadmap for the development of therapeutic interventions for PP2A:B55-related diseases.
Subject(s)
Cryoelectron Microscopy , Intracellular Signaling Peptides and Proteins , Intrinsically Disordered Proteins , Phosphoproteins , Protein Phosphatase 2 , Humans , Intracellular Signaling Peptides and Proteins/chemistry , Intracellular Signaling Peptides and Proteins/metabolism , Intrinsically Disordered Proteins/chemistry , Intrinsically Disordered Proteins/metabolism , Intrinsically Disordered Proteins/ultrastructure , Mitosis , Nuclear Magnetic Resonance, Biomolecular , Phosphoproteins/chemistry , Phosphoproteins/metabolism , Phosphoproteins/ultrastructure , Phosphorylation , Protein Phosphatase 2/chemistry , Protein Phosphatase 2/metabolism , Protein Phosphatase 2/ultrastructureABSTRACT
The protein phosphatase 2A (PP2A) heterotrimer PP2A-B56α is a human tumour suppressor. However, the molecular mechanisms inhibiting PP2A-B56α in cancer are poorly understood. Here, we report molecular level details and structural mechanisms of PP2A-B56α inhibition by an oncoprotein CIP2A. Upon direct binding to PP2A-B56α trimer, CIP2A displaces the PP2A-A subunit and thereby hijacks both the B56α, and the catalytic PP2Ac subunit to form a CIP2A-B56α-PP2Ac pseudotrimer. Further, CIP2A competes with B56α substrate binding by blocking the LxxIxE-motif substrate binding pocket on B56α. Relevant to oncogenic activity of CIP2A across human cancers, the N-terminal head domain-mediated interaction with B56α stabilizes CIP2A protein. Functionally, CRISPR/Cas9-mediated single amino acid mutagenesis of the head domain blunted MYC expression and MEK phosphorylation, and abrogated triple-negative breast cancer in vivo tumour growth. Collectively, we discover a unique multi-step hijack and mute protein complex regulation mechanism resulting in tumour suppressor PP2A-B56α inhibition. Further, the results unfold a structural determinant for the oncogenic activity of CIP2A, potentially facilitating therapeutic modulation of CIP2A in cancer and other diseases.
Subject(s)
Carcinogenesis , Protein Phosphatase 2 , Protein Processing, Post-Translational , Triple Negative Breast Neoplasms , Humans , Amino Acids , Carcinogenesis/genetics , Carcinogenesis/metabolism , Catalytic Domain , Phosphorylation , Protein Phosphatase 2/genetics , Protein Phosphatase 2/ultrastructure , Triple Negative Breast Neoplasms/metabolismSubject(s)
Multienzyme Complexes/chemistry , Multienzyme Complexes/metabolism , Protein Multimerization , Protein Phosphatase 2/chemistry , Protein Phosphatase 2/metabolism , Animals , Calmodulin-Binding Proteins/chemistry , Calmodulin-Binding Proteins/metabolism , Calmodulin-Binding Proteins/ultrastructure , Cryoelectron Microscopy , Hippo Signaling Pathway , Humans , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Membrane Proteins/ultrastructure , Models, Molecular , Multienzyme Complexes/ultrastructure , Nerve Tissue Proteins/chemistry , Nerve Tissue Proteins/metabolism , Nerve Tissue Proteins/ultrastructure , Protein Phosphatase 2/ultrastructure , Protein Serine-Threonine Kinases/chemistry , Protein Serine-Threonine Kinases/metabolism , Protein Subunits/chemistry , Protein Subunits/metabolism , Signal TransductionABSTRACT
The striatin-interacting phosphatase and kinase (STRIPAK) complex is a large, multisubunit protein phosphatase 2A (PP2A) assembly that integrates diverse cellular signals in the Hippo pathway to regulate cell proliferation and survival. The architecture and assembly mechanism of this critical complex are poorly understood. Using cryo-EM, we determine the structure of the human STRIPAK core comprising PP2AA, PP2AC, STRN3, STRIP1, and MOB4 at 3.2-Å resolution. Unlike the canonical trimeric PP2A holoenzyme, STRIPAK contains four copies of STRN3 and one copy of each the PP2AA-C heterodimer, STRIP1, and MOB4. The STRN3 coiled-coil domains form an elongated homotetrameric scaffold that links the complex together. An inositol hexakisphosphate (IP6) is identified as a structural cofactor of STRIP1. Mutations of key residues at subunit interfaces disrupt the integrity of STRIPAK, causing aberrant Hippo pathway activation. Thus, STRIPAK is established as a noncanonical PP2A complex with four copies of regulatory STRN3 for enhanced signal integration.
Subject(s)
Cryoelectron Microscopy , Multienzyme Complexes/metabolism , Multienzyme Complexes/ultrastructure , Protein Multimerization , Protein Serine-Threonine Kinases/metabolism , Adaptor Proteins, Signal Transducing/chemistry , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Autoantigens/chemistry , Autoantigens/genetics , Autoantigens/metabolism , Autoantigens/ultrastructure , Calmodulin-Binding Proteins/chemistry , Calmodulin-Binding Proteins/genetics , Calmodulin-Binding Proteins/metabolism , Calmodulin-Binding Proteins/ultrastructure , Hippo Signaling Pathway , Humans , Models, Molecular , Multienzyme Complexes/chemistry , Multienzyme Complexes/genetics , Mutation , Phosphate-Binding Proteins/chemistry , Phosphate-Binding Proteins/genetics , Phosphate-Binding Proteins/metabolism , Phosphate-Binding Proteins/ultrastructure , Phytic Acid/metabolism , Protein Phosphatase 2/chemistry , Protein Phosphatase 2/genetics , Protein Phosphatase 2/metabolism , Protein Phosphatase 2/ultrastructure , Protein Serine-Threonine Kinases/chemistry , Protein Subunits/chemistry , Protein Subunits/genetics , Protein Subunits/metabolism , Signal TransductionABSTRACT
Human T-cell lymphotropic virus type 1 (HTLV-1) is a deltaretrovirus and the most oncogenic pathogen. Many of the ~20 million HTLV-1 infected people will develop severe leukaemia or an ALS-like motor disease, unless a therapy becomes available. A key step in the establishment of infection is the integration of viral genetic material into the host genome, catalysed by the retroviral integrase (IN) enzyme. Here, we use X-ray crystallography and single-particle cryo-electron microscopy to determine the structure of the functional deltaretroviral IN assembled on viral DNA ends and bound to the B56γ subunit of its human host factor, protein phosphatase 2 A. The structure reveals a tetrameric IN assembly bound to two molecules of the phosphatase via a conserved short linear motif. Insight into the deltaretroviral intasome and its interaction with the host will be crucial for understanding the pattern of integration events in infected individuals and therefore bears important clinical implications.
Subject(s)
Human T-lymphotropic virus 1/pathogenicity , Integrases/ultrastructure , Protein Phosphatase 2/ultrastructure , Simian T-lymphotropic virus 1/enzymology , Viral Proteins/ultrastructure , Virus Integration , Amino Acid Motifs/genetics , Cloning, Molecular , Cryoelectron Microscopy , Crystallography, X-Ray , DNA, Viral/metabolism , DNA, Viral/ultrastructure , Human T-lymphotropic virus 1/enzymology , Human T-lymphotropic virus 1/genetics , Humans , Integrases/genetics , Integrases/metabolism , Leukemia-Lymphoma, Adult T-Cell/pathology , Leukemia-Lymphoma, Adult T-Cell/virology , Molecular Docking Simulation , Mutagenesis, Site-Directed , Paraparesis, Tropical Spastic/pathology , Paraparesis, Tropical Spastic/virology , Protein Multimerization , Protein Phosphatase 2/genetics , Protein Phosphatase 2/metabolism , Protein Structure, Quaternary , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/ultrastructure , Sequence Homology, Amino Acid , Simian T-lymphotropic virus 1/genetics , Single Molecule Imaging , Viral Proteins/genetics , Viral Proteins/metabolismABSTRACT
Integration of the reverse-transcribed viral DNA into host chromosomes is a critical step in the life-cycle of retroviruses, including an oncogenic delta(δ)-retrovirus human T-cell leukemia virus type-1 (HTLV-1). Retroviral integrase forms a higher order nucleoprotein assembly (intasome) to catalyze the integration reaction, in which the roles of host factors remain poorly understood. Here, we use cryo-electron microscopy to visualize the HTLV-1 intasome at 3.7-Šresolution. The structure together with functional analyses reveal that the B56γ (B'γ) subunit of an essential host enzyme, protein phosphatase 2 A (PP2A), is repurposed as an integral component of the intasome to mediate HTLV-1 integration. Our studies reveal a key host-virus interaction underlying the replication of an important human pathogen and highlight divergent integration strategies of retroviruses.
